Package 21130-180-79

Brand: signature care naproxen sodium

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 21130-180-79
Digits Only 2113018079
Product NDC 21130-180
Product ID 21130-180_347809fc-ce5e-49ff-b4e5-a36aa9eb6a72
Description

400 TABLET, FILM COATED in 1 BOTTLE (21130-180-79)

Marketing

Marketing Status
Discontinued 2027-02-28
Brand signature care naproxen sodium
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

signature care naproxen sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "347809fc-ce5e-49ff-b4e5-a36aa9eb6a72", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574"], "spl_set_id": ["85f78e63-98aa-4cf3-887d-0ac535184f97"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "400 TABLET, FILM COATED in 1 BOTTLE (21130-180-79)", "package_ndc": "21130-180-79", "marketing_end_date": "20270228", "marketing_start_date": "20211123"}], "brand_name": "signature care naproxen sodium", "product_id": "21130-180_347809fc-ce5e-49ff-b4e5-a36aa9eb6a72", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "21130-180", "generic_name": "Naproxen Sodium", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "signature care naproxen sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA074661", "marketing_category": "ANDA", "marketing_end_date": "20270228", "marketing_start_date": "20180403"}